Health In Tech vs Ethos Technologies
HIT and LIFE side by side, both in insurance agents, brokers, and service. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HIT and LIFE compare
Ethos Technologies is the larger company, worth 82 times as much as Health In Tech ($2.1B against $25.9M).
Ethos Technologies keeps more of each dollar of sales as profit, with a net margin of −16.2% compared with −37.1% at Health In Tech.
Ethos Technologies scores higher on the StockData Score (4 against 2 for Health In Tech), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HIT | LIFE |
|---|---|---|
| Size and price | ||
| Market cap | $25.9M | $2.1B |
| Share price | $0.396 | $33.26 |
| Change, 1 year | −78.4% | 1651% |
| Beta (5Y) | 1.29 | 4.89 |
| Employees | 87 | 614 |
| StockData Score | ||
| Total score | 2 | 4 (better) |
| Valuation score | 1 | 2 (better) |
| Growth score | 0 | 1 (better) |
| Performance score | 0 | 0 |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.8× (better) | 2.9× |
| P/B | – | 4.1× |
| P/FCF | – | 19.1× |
| FCF yield | – | 5.2% |
| Growth | ||
| Revenue growth (TTM) | 0.65% | – |
| Net income growth (TTM) | −898% | – |
| EPS growth (TTM) | −733% | – |
| Profitability | ||
| Gross margin | 50.5% | 98.1% (better) |
| Operating margin | – | −16.1% |
| Net margin | −37.1% | −16.2% (better) |
| FCF margin | – | 15.2% |
| Return on equity | −66.8% | −58.1% (better) |
| Return on invested capital | – | −230% |
| Financial health | ||
| Current ratio | 1.13 | 1.47 (better) |
| Altman Z-score | 1.92 | 4.49 (better) |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 7.1% | 27.7% |
| Held by insiders | 76.6% | 74.6% |
| Insider net buying, 12 months | −$40.6K (better) | −$89.6M |
| Short interest, % of float | 3.9% | 22.7% |
Go deeper
- HIT stock overview
- HIT income statement
- HIT valuation and score
- LIFE stock overview
- LIFE income statement
- LIFE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.